pantoprazole has been researched along with Pneumonia, Viral in 1 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Pneumonia, Viral: Inflammation of the lung parenchyma that is caused by a viral infection.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stoll, F | 1 |
| Blank, A | 1 |
| Mikus, G | 1 |
| Czock, D | 1 |
| Foerster, KI | 1 |
| Hermann, S | 1 |
| Häußler, K | 1 |
| Muhareb, A | 1 |
| Hummler, S | 1 |
| Weiss, J | 1 |
| Burhenne, J | 1 |
| Haefeli, WE | 1 |
1 trial available for pantoprazole and Pneumonia, Viral
| Article | Year |
|---|---|
Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Corona Virus Disease-19 (Covid-19): A structured summary of a study protocol for a randomised controlled trial.
Topics: Adolescent; Adult; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug | 2020 |